Kelman Lazarov, Inc. Novartis Ag Transaction History

Kelman Lazarov, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 27, 2020	SELL	$70.67 - $99.01 $171,728 - $240,594	-2,430 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$85.54 - $94.26 $98,371 - $108,399	-1,150 Reduced 32.12%	2,430 $211,000
Q2 2019 Jul 22, 2019	SELL	$75.4 - $92.8 $131,497 - $161,843	-1,744 Reduced 32.76%	3,580 $327,000
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $40,145 - $45,917	-533 Reduced 9.1%	5,324 $512,000
Q4 2018 Feb 11, 2019	SELL	$73.66 - $82.02 $64,894 - $72,259	-881 Reduced 13.08%	5,857 $503,000
Q2 2018 Aug 03, 2018	SELL	$64.91 - $73.36 $21,744 - $24,575	-335 Reduced 4.74%	6,738 $509,000
Q1 2018 May 08, 2018	SELL	$70.39 - $84.15 $31,675 - $37,867	-450 Reduced 5.98%	7,073 $572,000
Q3 2017 Oct 05, 2017	BUY	$74.14 - $77.27 $557,755 - $581,302	7,523	7,523 $646,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Kelman Lazarov, Inc., based on Form 13F filings with the SEC.

Stay updated on Kelman Lazarov, Inc. with notifications on news.